Abiraterone ACTe film-coated tablets contains a medicine called abiraterone acetate. It is used to treat prostate cancer in adult men that has spread to other parts of the body. Abiraterone stops your body from making testosterone; this can slow the growth of prostate cancer.
Bendamustine ACTe is a type of chemotherapy drug called an alkylating agent. These drugs work by interfering with the DNA in cancer cells. It is used to treat CLL/SLL and non-hodgkin's lymphomas.
Bratoma contains a medicine called temozolomide. This medicine is an antitumor agent. Bratoma is used for the treatment of specific forms of brain tumors.
Carboxa contains the active substance carboplatin. Carboxa is a medicine that is used to treat cancer of the ovaries. It acts by interfering with the division of rapidly multiplying cells, particularly cancer cells.
Dotixa contains the active substance dasatinib. Dotixa is used to treat Philadelphia chromosome positive (pH+) Chronic Lymphoblastic Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL) in adults, adolescents, and children at least 1 year of age who are not benefiting from prior therapies.
Evacim contains the active substance bevacizumab, which is a humanised monoclonal antibody. Evacim binds selectively to a protein called human vascular endothelial growth factor (VEGF), which is found on the lining of blood and lymph vessels in the body. The VEGF protein causes blood vessels to grow within tumours, these blood vessels provide the tumour with nutrients and oxygen. Once bevacizumab is bound to VEGF, tumour growth is prevented by blocking the growth of the blood vessels which provide the nutrients and oxygen to the tumour.
Evrolia is an anticancer medicine containing the active substance everolimus. Evrolia reduces the blood supply to the tumour and slows down the growth and spread of cancer cells.
The active substance in Fracta is zoledronic acid, which belongs to a group of substances called bisphosphonates. Fracta works by attaching itself to the bone and slowing down the rate of bone change.
Ibract is an anticancer medicine containing the active substance palbociclib. Palbociclib works by blocking proteins called cyclin-dependent kinase 4 and 6, which regulate cell growth and division. Blocking these proteins can slow down growth of cancer cells and delay the progression of cancer.
